IMMATICS BIOTECHNOLOGIES GMBH -  

Ranking results:

Past rankings:

2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 4
As coordinator: 1
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0.33*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 0 6.001.482 1.300.650 1
2013 0 5.996.111 1.934.200 1
2012 5.970.436 5.717.979 1.317.976 1 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
EBERHARD KARLS UNIVERSITAET TUEBINGEN3
REGION HOVEDSTADEN2
ACADEMISCH ZIEKENHUIS GRONINGEN1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
BCN PEPTIDES1
BIONTECH1
BIONTECH INNOVATIVE MANUFACTURING SERVICES1
CENTRUM ONKOLOGII INSTYTUT IM MARII SKLODOWSKIECURIE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CUREVAC THE RNA PEOPLE1
DCPRIME BV1
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA1
HELSE BERGEN HFHAUKELAND UNIVERSITY HOSPITAL1
HELSINGIN YLIOPISTO1
IMMUNOLOGISCHE KREBSTHERAPIE EV1
INSTITUT CATALA DE LA SALUT1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
ISTITUTO NAZIONALE TUMORI FONDAZIONE PASCALE1
LEIDEN UNIVERSITY MEDICAL CENTER1
LINICAL ACCELOVANCE EUROPE BV1
MEDIZINISCHE UNIVERSITAT GRAZ1
PHILOGEN1
STICHTING VU1
STICHTING VUMC1
TECHNION ISRAEL INSTITUTE OF TECHNOLOGY1
TECHNISCHE UNIVERSITAET DRESDEN1
THE UNIVERSITY OF NOTTINGHAM1
UNIVERSIDAD DE NAVARRA1
UNIVERSITA DEGLI STUDI DELL'INSUBRIA1
UNIVERSITAETSKLINIKUM BONN1
UNIVERSITAETSKLINIKUM ESSEN1
UNIVERSITAETSKLINIKUM HEIDELBERG1
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ1
UNIVERSITAIR ZIEKENHUIS ANTWERPEN1
UNIVERSITE DE GENEVE1
UNIVERSITETET I BERGEN1
UNIVERSITY OF BIRMINGHAM1
UNIVERSITY OF GLASGOW1
UNIVERSITY OF SOUTHAMPTON1
UPPSALA UNIVERSITET1

Constancy:

Total number of partners: 43
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 40
Frequent / Rare Partner Ratio: 0.08

Project overview:

Start dateProjectacronymrolefundingpartners
2016-01-01Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia AML-VACCiNparticipant6.001.48214
2013-09-01Cancer Vaccine development for Hepatocellular Carcinoma HEPAVACparticipant5.996.1119
2012-11-01Glioma Actively Personalized Vaccine Consortium GAPVACcoordinator5.970.43613
2012-01-01IMmune MOdulating strategies for treatment of MErkel cell Carcinoma IMMOMECparticipant5.717.97911